Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 77 (Search time: 0.004 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2015New pharmacokinetic/pharmacodynamic studies of systemically administered colistin against Pseudomonas aeruginosa and Acinetobacter baumannii in mouse thigh and lung infection models: smaller response in lung infectionCheah, S.; Wang, J.; Van, T.; Turnidge, J.; Li, J.; Nation, R.
1999Pharmacokinetics and pharmacodynamics of fluoroquinolonesTurnidge, J.
2001Responsible prescribing for upper respiratory tract infectionsTurnidge, J.
2001Multicentre study of the in vitro activity of cefepime, a broad-spectrum cephalosporin, compared to other broad-spectrum agentsBell, J.; Turnidge, J.
2001Integration of molecular characterization of microorganisms in a global antimicrobial resistance surveillance programPfaller, M.; Acar, J.; Jones, R.; Verhoef, J.; Turnidge, J.; Sader, H.
2001Characterization of Pseudomonas aeruginosa isolates: Occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997-1999Gales, A.; Jones, R.; Turnidge, J.; Rennie, R.; Ramphal, R.
2009Emergence and widespread dissemination of OXA-23,-24/40 and-58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance ProgramMendes, R.; Bell, J.; Turnidge, J.; Castanheira, M.; Jones, R.
2013Multicenter Study of Isavuconazole MIC Distributions and Epidemiological Cutoff Values for Aspergillus spp. for the CLSI M38-A2 Broth Microdilution MethodEspinel-Ingroff, A.; Chowdhary, A.; Gonzalez, G.; Lass-Florl, C.; Martin-Mazuelos, E.; Meis, J.; Pelaez, T.; Pfaller, M.; Turnidge, J.
2016Predictability of phenotype in relation to common β-lactam resistance mechanisms in Escherichia coli and Klebsiella pneumoniaeAgyekum, A.; Fajardo-Lubián, A.; Ai, X.; Ginn, A.; Zong, Z.; Guo, X.; Turnidge, J.; Partridge, S.; Iredell, J.
2011Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high Vancomycin minimum inhibitory concentrationsHolmes, N.; Turnidge, J.; Munckhof, W.; Robinson, J.; Korman, T.; O'Sullivan, M.; Anderson, T.; Roberts, S.; Gao, W.; Christiansen, K.; Coombs, G.; Johnson, P.; Howden, B.